Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves...

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Cardiac contractility is crucial for maintaining heart function.
• Alpha1A-adrenergic receptors (alpha1A-AR) play a role in regulating myocardial contractility.
• Transgenic models allow investigation of specific gene functions in cardiovascular disease.

Purpose of the Study:

• To investigate if enhanced inotropy from alpha1A-AR overexpression protects against cardiac dysfunction and remodeling post-myocardial infarction (MI).

Main Methods:

• Transgenic (TG) mice overexpressing cardiac alpha1A-AR and non-TG (NTG) littermates were subjected to MI.
• Left ventricular (LV) function and dimensions were assessed using echocardiography over 15 weeks.
• Mortality and cardiac remodeling markers were compared between TG and NTG groups.

Main Results:

• Mortality due to heart failure was significantly lower in alpha1A-TG mice compared to NTG mice post-MI.
• While initial LV dysfunction was similar, alpha1A-TG mice exhibited significantly less LV remodeling and preserved fractional shortening compared to NTG mice over 15 weeks.
• LV catheterization at 15 weeks revealed better preservation of contractility (dP/dtmax) in alpha1A-TG mice.

Conclusions:

• Overexpression of alpha1A-AR enhances cardiac inotropy, providing chronic protection after MI.
• This protection limits LV remodeling, preserves cardiac function, and reduces mortality from heart failure post-MI.